CAN DIABETIC PATIENTS EAT JAGGERY ?

IS JAGGERY GOOD FOR DIABETIC PATIENTS ?

Being diabetic often triggers sweet cravings. And when sugar is out of limit, you look for non-sugary alternates, one of which is jaggery. Believed to be a great alternative for sugar, jaggery indeed has a number of health benefits. But is it really a healthy choice for diabetics? Let’s have a look.


IS IT AS BAD AS SUGAR? 

Jaggery is a traditional form of sweetener. It is obtained by boiling clarified sugarcane juice. This solid residue is less refined when compared to sugar and retains a lot of essential nutrients such as potassium, iron and calcium. But that doesn’t mean a person with high sugar level can eat jaggery. Its brown colour may seem healthy but for a diabetic patient, it is not a healthy choice. Jaggery does help in fighting oxidative stress and maintains blood pressure because of its iron content, but if you’re a diabetic, jaggery should be out of your food limits.


JAGGERY CONTAINS SUGAR: 

Yes, a lot of sugar! Jaggery is a nutrient-rich sweetener but this sweet-alternate also contains about 65 to 85 per cent of sucrose. And this is the reason that eating jaggery should be a big no for diabetics, as the bulk of it is sugar!


IT CAN CAUSE HIGH SUGAR LEVEL: 

Eating jaggery has somewhat similar effect on your glucose level as eating sugar. Many people have the perception that when they replace sugar with jaggery, it can help them maintain their blood sugar level. But this is not the case. Though complex, jaggery contains sucrose, which when absorbed by our body raises blood sugar levels. That means it is as harmful as any other form of sugar. The only difference is jaggery takes time to get absorbed in the body.
People who don’t have diabetes can replace sugar with jaggery. This is a healthy choice for them. Doctors recommend a low Glycemic Index diet for diabetics. Hence eating jaggery is not an option for them.


WHAT AYURVEDA SAY? 

Even Ayurveda doesn’t recommend jaggery for diabetic patients. Ayurveda uses jaggery to treat lung infections, sore throat, migraines, and asthma. And this ancient form restricts diabetics to use jaggery in their diet. Ayurveda has listed jaggery as an ' offender’ for a diabetic's diet.


SOURCE : https://timesofindia.indiatimes.com/life-style/health-fitness/can-diabetic-patients-eat-jaggery/what-ayurveda-say/photostory/61878327.cms

NEW BLOOD PRESSURE GUIDELINE 

New guidelines were released on tips to lower blood pressure. 

The American Heart Association is calling for more aggressive control of high blood pressure to reduce complications with hypertension and diabetes. 

The recommendation is based on a series of studies that show 130 over 80 as the new target. 

At one point, doctors were okay with high numbers like 140 over 90, which is now deemed stage two hypertension. 

Many South Georgians are already in stage two and require immediate treatment.

"These recommendations are based on good data and I have high confidence that they will help patients and prevent disease," said Dr. Derrick Taylor, Phoebe Primary Care Physician at Tower One. 

More aggressive blood pressure treatment could include more medication and a lifestyle change such as exercise, weight loss, low-fat diets, and no smoking

SOURCE : http://www.walb.com/story/36892742/american-heart-association-releases-new-blood-pressure-guidelines

Diabetics may not feel classic heart attack symptoms

People with diabetes are three times more likely to die from heart disease than the general population

New Delhi: People with diabetes may not always feel classic symptoms like acute chest pain when they have a heart attack, according to a small study that offers a potential explanation for why these episodes are more deadly for diabetics.

Researchers examined data from detailed interviews with 39 adults in the UK who had been diagnosed with diabetes and had also experienced a heart attack. Most of the participants reported feeling some chest pain, but they often said it didn’t feel like they expected or that they didn’t think it was really a heart attack.

“Long term diabetes damages your heart in many ways (increased blocking of the heart’s blood vessels), but it also damages your nerves,” said study co-author Dr. Melvyn Jones of University College London.

 “So a bit like a diabetic might not feel the stubbing of their toe, they also feel less pain from damaged heart muscle when the blood supply gets cut off, so they don’t get the classical crushing chest pain of a heart attack,” Jones said by email.

People with diabetes are three times more likely to die from heart disease than the general population and possibly six times more likely to have a heart attack, Jones added.

All patients in the study received care at one of three hospitals in London, and they ranged in age from 40 to 90. Most were male, and roughly half were white.

The majority had what’s known as type 2 diabetes, which is tied to aging and obesity and happens when the body can’t properly use insulin to convert blood sugar into energy. Four of them had type 1 diabetes, a lifelong condition that develops when the pancreas produces little or no insulin, a hormone needed to allow blood sugar to enter cells.

Many of the participants described heart attack symptoms such as chest pain and discomfort.

However, many felt like their pain wasn’t severe enough to be a heart attack or didn’t consider the discomfort they felt in their chest as similar to what they would expect with a heart attack.

This may have contributed to delays in seeking care, which are in turn associated with lower survival odds and a higher risk of complications and disability for people who do live through the event, researchers note in the journal BMJ Open.

The study was small, and it wasn’t a controlled experiment designed to prove whether or how diabetes might lead people to experience different heart attack symptoms.

Still, it confirms a longstanding belief that people with diabetes may be prone to atypical heart attack symptoms, said Dr. Deepak Bhatt, executive director of Interventional Cardiovascular Programs at Brigham and Women’s Hospital Heart and Vascular Center and a researcher at Harvard Medical School in Boston.

“Atypical means instead of the more classic chest pain or chest pressure, patients experience symptoms such as extreme fatigue or breathlessness, for example,” Bhatt, who wasn’t involved in the study, said by email.

“The biology of the heart attack is the same,” Bhatt added. “But the thought is that patients with advanced diabetes may have a degree of nerve damage (neuropathy) and therefore may be less likely to experience the more common chest pain or chest pressure from a heart attack.”

Patients with diabetes should understand that they’re more likely to have a heart attack than other people, said Dr. John Wilkins, a researcher at Northwestern University Feinberg School of Medicine in Chicago who wasn’t involved in the study.

“They should have regular follow-up with their physicians, keep their blood sugars well controlled, lead a heart-healthy lifestyle, avoid the development of cardiovascular risk factors like high blood pressure and high cholesterol, and if they have risk factors they should make sure they are appropriately managed,” Wilkins said by email.

“They should also be familiar with the symptoms that suggest that they might be having a heart attack or an impending heart attack and know how to respond if those symptoms develop,” Wilkins advised.

source :http://zeenews.india.com/health/diabetics-may-not-feel-classic-heart-attack-symptoms-2051609 

Wife’s Obesity Could Increase Risk of Diabetes in Men :

According to a latest study, a wifes obese condition can not only up her diabetes risk but her husbands too.

Obesity is a disorder involving excessive body fat that increases the risk of various other health problems. For the longest time, experts have studied the effect of obesity on an individual in detail, but according to a latest study, a wife’s obese condition can not only up her diabetes risk but her husband’s too. The study revealed that obesity can substantially increase her risk of developing Type 2 diabetes, especially in middle age -- but women with an obese husband have no additional risk.

The study revealed that for every 5 kg/m2 higher BMI in a wife, the husband's Type 2 diabetes risk was 21 per cent higher when accounting for the man's own BMI.
Adam Hulman from Aarhus University in Denmark said, "Having an obese wife increases a man's risk of diabetes over and above the effect of his own obesity level, while among women, having an obese husband gives no additional diabetes risk beyond that of her own obesity level.”

"Our results indicate that on finding obesity in a person, screening of their spouse for diabetes may be justified," Hulman added.

The research, also suggests that people over 55 with a spouse with Type 2 diabetes tend to be more obese than their peers without a diabetic partner.

The study presented at the 2017 European Association for the Study of Diabetes (EASD) Annual Meeting in Lisbo further explained that obesity or Type 2 diabetes in one partner could lead to Type 2 diabetes in the other due to the many risk behaviours which often leads to diabetes shared by couples, such as unhealthy eating habits and inadequate physical activity.

"Recognising shared risk between spouses may improve diabetes detection and motivate couples to increase collaborative efforts to eat more healthily and boost their activity levels," Hulman said.



From heart diseases to diabetes, being heavily overweight can prove to be a harbinger of many health risks. Here are some effective ways  which can come in handy to tackle obesity:

1.Include more whole grains in your meal: .Whole grain provide energy to sustain and grow and are also a major source of all essential nutrients. Ditch processed cereals and load up on whole grains like Bajra, Ragi, Maize and Jowar, and use them often. Try brown rice instead of white rice .

2.Keep the trans fats away: Industrial trans fats are often present in fast foods, street snacks, fried foods, cookies, margarine and spreads. Read the labels; if there is no label, find a better substitute.

3.Do not skip meals: Eat three balanced meals. Take a standard dinner plate, fill ½ with vegetables, 1/3rd with cereal, 1/3rd with protein, and add 150 ml of milk/dahi/dessert.

4.Limit your intake of sugar: Sugar is a source of many excess calories which practically does nothing for your body, and goes on storing as fat. While it is important to stay away from refined sugars, do note that a lot of foods have natural sugar hidden in them too. It  is advisable to keep the  intake less than 10% of your total calories. For a normal weight woman who needs 1900Kcal/day this is about 10 -11 teaspoons of sugar.

5.Eat protein with every meal: Proteins take longer to digest which means that they keep you full for longer and also help in reducing the total body fat. Having protein-rich foods like amaranth, sprouts, peas, and eggs helps in accelerating weight.

SOURCE : https://www.ndtv.com/food/wife-s-obesity-could-increase-risk-of-diabetes-in-men-5-handy-tips-to-keep-obesity-in-check-1749610

TAKE CARE OF YOUR FEET MORE THAN YOUR FACE

We all know that India is fast becoming the diabetes capital of the world. There are about 69.2 million diabetes patients in India which is expected to reach 123.5 million by the year 2040.

Development of foot ulceration is a common problem in patients with longstanding diabetes. Life time risk of developing foot ulcer may be as high as 25%. Foot ulceration is one of the leading causes of hospital admission in patients with diabetes mellitus. 60% of admissions in diabetes patients are for foot problems. 1% of diabetes patients may lose a portion of their limb in lifetime. In India prevalence of foot ulcer in people with diabetes is 3%.

The reason why diabetes patients are more prone to foot problems are vasculopathy i.e. involvement of blood vessels, neuropathy i.e. involvement of nerves, development of infection and many other co-existing problems such as old age, immunosuppressive states, hypoproteinemia and poor blood sugar control. The blood vessels in diabetic patients are affected by atherosclerosis i.e. deposition of fat inside blood vessels causing lead pipe arteries with resultant loss of its elastic property. Further calcification of blood vessels lead to poor distal blood flow.

Neuropathy, the involvement of nerves can occur because of autonomic, sensory and motor neuropathy. Autonomic neuropathy is the loss of autonomic control resulting in inhibition of thermoregulatory function and sweating. It results in dry, scaly and stiff skin that is prone to cracking and allows the entry of bacteria. Sensory neuropathy is the loss of protective sensation. It starts distally and migrates proximally in stocking distribution. Motor neuropathy results in foot deformities like hammer toes, claw toes, hallux valgus and flat feet.

Presence of high plantar pressure due to obesity, deformities in the foot, limited joint mobility further leads to development of foot ulcer. Ill-fitting footwear may further aggravate the situation. Majority of ulcer occur below head of 1 st metatarsophalangeal joint. Diabetic foot are usually classified as neuropathic foot or neuroischaemic foot meaning either only nerve is involved or both nerve and blood vessels are involved. There are various type of therapy available to treat diabetic foot ulcer ranging from simple surgical debridement to hyperbaric O 2 therapy, vacuum therapy, injections of G-CSF/Zolendronate.

Prevention of the developing ulcer is better than cure
*Feet should be washed daily using warm water and soap. After washing, feet should be dried with a dry towel especially between the toes followed by application of moisturizing lotion.
*Avoid wearing socks with rough seams as seamless diabetic socks are available.
*Toe nails should be trimmed regularly. Ingrown toe nails should not be removed at home.
*Avoid cutting nails if they are thick or hard and visit a local chiropodist.
*Corns and calluses should not be trimmed with scissors, knives or razor blades.
*Foot care should be a routine in the life of a diabetic along with good blood sugar control.

SOURCE : http://timesofindia.indiatimes.com/life-style/health-fitness/every-heart-counts/take-care-of-your-feet-more-than-your-face/articleshow/60837360.cms

Diabetes, heart disease linked by same genes: Study






According to a study, there could be a link between diabetes and coronary heart disease. the diseases appears to work in one direction so that risk genes for Type 2 diabetes are much more likely to be associated with higher coronary heart disease risk than the other way around.

Using evidence from human genetics, it should be possible to design drugs for Type-2 diabetes that have either beneficial or neutral effects on coronary heart disease risk. 

Researchers have identified gene variants that boost the risk of developing Type 2 diabetes and coronary heart disease — the leading cause of global morbidity and mortality, a finding that points to potential targets for common drugs.

While the study confirmed most of the known diabetes “risk loci” — sites on the genome where small DNA variations have been linked to altered, usually higher diabetes risk — the researchers also uncovered 16 new risk factors.

The researchers also identified eight specific gene variants that are strongly linked to altered risk for both diseases. “Identifying these gene variants linked to both Type 2 diabetes and coronary heart disease risk in principle opens up opportunities to lower the risk of both outcomes with a single drug,” said co-senior author Danish Saleheen, Assistant Professor at the University of Pennsylvania in the US.

“From a drug development perspective, it would make sense to focus on those pathways that are most strongly linked to both diseases.” Seven of these gene variants, as expected, appeared to increase risk for both Type 2 diabetes and coronary heart disease risk. The eighth, a variant of the gene for the cholesterol-transport protein ApoE, turned out to be associated with higher diabetes risk but lower coronary heart disease risk.

On the whole, the genetic link between the diseases appears to work in one direction so that risk genes for Type 2 diabetes are much more likely to be associated with higher coronary heart disease risk than the other way around, the researchers explained in the paper published in the journal Nature Genetics.

There could also be some pathways where pharmacological lowering of one disease increases the risk of the other. “Using evidence from human genetics, it should be possible to design drugs for Type-2 diabetes that have either beneficial or neutral effects on coronary heart disease risk,” Saleheen said.

source : http://indianexpress.com/article/lifestyle/health/diabetes-heart-disease-linked-by-same-genes-study-4830026/

Immunotherapy May Lead to Cure for Type 1 Diabetes

The results of a new study published by Science Translational Medicine suggest that it might be possible to retrain the immune system to prevent or slow attacks on insulin-producing beta cells.

In the MonoPepT1De trial, the authors discovered changes in the immune system of patients with type 1 diabetes were injected with peptides, which are small fragments of the protein found in pancreatic beta cells.

Type 1 diabetes occurs when the body attacks insulin-producing beta cells. Without treatment, the number of beta cells will diminish and the patient will be unable to control blood glucose levels.

“When someone is diagnosed with type 1 diabetes they still typically have between 15% and 20% of their beta cells. We wanted to see if we could protect these remaining cells by retraining the immune system to stop attacking them,” said researcher Mark Peakman, PhD. “We still have a long way to go, but these early results suggest we are heading in the right direction. The peptide technology used in our trial is not only safe for patients, but it also has a noticeable effect on the immune system.”

Currently, there is no cure for type 1 diabetes. Without proper glycemic control, patients can experience problems with the heart, blood vessels, nerves, eyes, and kidneys.

The study results suggest that immunotherapy may stop immune attacks on beta cells and prevent glycemic issues, according to the authors.

“It was encouraging to see that people who receive the treatment needed less insulin to control their blood glucose levels, suggesting that their pancreas was working better” said chief investigator Colin Dayan, PhD.

Following the success of the clinical trial, researchers are collaborating with UCB Biopharma to develop MultipepT1De as a next generation product and conduct a phase 1b study evaluating the safety of the treatment, according to the study.

If proven effective, patients may no longer require daily, life-long insulin therapy.

“Exciting immunotherapy research like this increases the likelihood that one day insulin-producing cells can be protected and preserved,” said Karen Addington, UK chief executive of JDRF, which funded the research. “That would mean people at risk of Type 1 diabetes might one day need to take less insulin, and perhaps see a future where no one would ever face daily injections to stay alive.”

SOURCE : https://www.specialtypharmacytimes.com/news/immunotherapy-may-lead-to-cure-for-type-1-diabetes

Gestational diabetes is a more serious problem in India than in other parts of the world: Dr Nam Han Cho

The GDM (Gestational Diabetes Mellitus) rate in India is 26.3%, which is highest in the world, according to Dr Nam Han Cho. Gestational diabetes is a serious form of diabetes which occurs during pregnancy.



New Delhi: Dr Nam Han Cho, president-elect of International Diabetes Federation (IDF), was recently in India to co-inaugurate Dr Mohan’s International Diabetes Update 2017. A world renowned diabetes epidemiologist, Dr Cho has published over 80 peer reviewed papers on type-1 & type-2 diabetes and gestational diabetes. He is also founder of the type-1 diabetes registry in Korea and is also responsible for estimating the prevalence of type 2 diabetes for the Korean population.

In an email interview with ETHealthworld, Dr Nam Han Cho provided insights on to the state of diabetes in India.

How do IDF’s South East Asia regions function? What are your observations/findings in diabetes for India?

The South East Asia (SEA) region is one of the seven IDF regions. It is the most active region for promoting diabetes awareness and advocacy, providing patient & professional education and humanitarian support, hosting numerous international congresses for professionals, as well as conducting quality public health and clinically related diabetes researches.

Diabetes in India is a more serious problem than in other parts of the world. Indians stand at second highest number of people living with diabetes, especially highest in gestational diabetes in the world. A rapid economic growth, sedentary lifestyles and urbanization alter national culture and social structures, and eventually will put more people at high risk of diabetes in the future.

What do you have to say about high glycaemia cases in pregnancy? What are the solutions to such cases? How is the situation in India?

GDM (Gestational Diabetes Mellitus) issues in India are more problematic than the rest of the world. We do not know the exact cause but Indians are at higher risk for gestational diabetes. Gestation diabetes is a serious form of diabetes which occurs during pregnancy. The GDM rate in India is 26.3%, and it is the highest in the world. GDM has significant adverse health impacts on both foetus and mother. Offspring of GDM shows increased risk of both short-term and long-term adverse health effects. For short-term adverse effects, numerous reports show increased frequency of macrosomia, hypoglycaemia, persistent hypoglycaemia, hypocalcaemia, hyperbilirubinaemia, transient tachypnoea, polycythaemia, respiratory distress syndrome and intra-uterine growth retardation. For long-term adverse health effects, ailments like central nervous system (CNS), congenital heart disease, respiratory disease, intestinal atresia, anal atresia, renal & urinary defect, upper limb deficiencies, lower limb deficiencies, upper + lower spine, and caudal dysgenesis have been reported. Furthermore, there are high chances of pre-diabetes and diabetes in the offspring of GDM. Thus, the best solution to solve these problems is to detect GDM at early stage of pregnancy by frequent screening. It is also advisable to control high glucose level throughout the pregnancy.

What latest have you observed in diabetes for the year 2017, specific to the Southeast Asia population?

The latest issues of diabetes in SEA are inclining number of diabetes cases, increased level of obesity with limited access or no access to medicine and/or medical care. The Southeast Asian population has also been presented with a high number of undiagnosed diabetes cases, more than 52% cases, as well as a high level of diabetes related mortalities in people less than 60 years of age. All these were discussed in the 4th edition of ‘Dr Mohan’s International Diabetes Update’ in Chennai.

What are the global challenges involved in endocrinology? What solutions could be implemented?

The global challenge in endocrinology is how to win the war against diabetes. We have observed that every 7 seconds, one person dies from diabetes-related complications. In 2015, diabetes caused almost 5 million deaths worldwide, almost half of them were people under 60 years of age. Diabetes intersects with all major dimensions of global development, including poverty reduction, gender equality or education. The costs of treatment and care push individuals and households into cycles of catastrophic expenditure and impoverishment. Also, poverty and the social determinants of health increase exposure and vulnerability to diabetes. Diabetes is currently unstoppable, thus utilization of risk factors for undiagnosed cases and identification of high risk populations accompanied with early management may be the roles for endocrinology to stop the war against diabetes.

What would be the one thing that you wish to bring in India for diabetes care?

If I may, one thing I wish to bring in India for diabetes care is a message, “Learn how to live with diabetes”. Diabetes is no longer stranger to us or Indians. It is a part of our life. No one is protected from diabetes and no places are safe from diabetes. Thus, it is better to learn how to live with it. The best way to win a war is to know your enemy better. In other words, learn to live with diabetes so that we know how to prevent, manage and live normal life without fear of diabetes.

What are the future plans for IDF, anything in plans specific to India?

IDF is an international organization consisting of almost 170 countries with more than 230 member associations. Our strength is global network, thus our plan is to tackle diabetes at international level but focus on each region including each country’s culture, economic status and social structures. IDF’s long-term plans are to strengthen diabetes education for both patients and healthcare providers via IDF School of Diabetes, diabetes retinopathy screening project in low and middle income countries, diabetes foot care project, humanitarian “diabetat” project, diabetes in women, and blue circle voice for advocacy are in the packet as the future plans.

For India, IDF hopes to see that Indian women leaders take the “Diabetes in Women” project into the future and nurture it to become the reference model for better care of women living with diabetes, as well as promote it to be the global women’s health project.

source : http://health.economictimes.indiatimes.com/news/industry/gestation-diabetes-is-a-more-serious-problem-in-india-than-in-other-parts-of-the-world-dr-nam-han-cho/59883430

DIABETES DRUG - EXENATIDE MAY BE HELPFUL FOR PARKINSON'S DISEASE.

"A drug commonly used to treat diabetes could help those living with Parkinson's disease," The Guardian reports. A small study suggests a drug called exenatide may have a modest beneficial effect on motor (movement) symptoms in people with Parkinson’s diaease.

Exenatide is known as a GLP-1 agonist, used to help regulate blood sugar levels in people with diabetes. Previous, early-stage research also suggests it may help protect nerves against damage, which is the root cause of Parkinson's.

The study looked at changes to people's movement ("motor") ability when given either an injection of exenatide or a placebo injection. The people in the study had their motor ability assessed by a well-validated scoring tool before taking the drug, at various points during the trial, and 12 weeks after they were last treated.

At the final measuring point, people who had received exenatide had shown a small improvement in their motor scores, while people in the placebo group had got worse. However, the difference between those changes was modest. People receiving exenatide did not report any significant improvement in quality of life.

Nonetheless, it is an interesting finding warranting further research into the longer-term effects of giving exenatide to people with Parkinson's disease.

It could be the case that a repurposed GLP-1 agonist specifically designed to treat Parkinson's would provide more benefit.

Source : http://www.nhs.uk/news/2017/08August/Pages/Diabetes-drug-may-be-helpful-for-Parkinsons-disease.aspx

Once-a-month diabetes treatment may replace daily insulin jabs

The new biopolymer injection has the potential to replace daily or weekly insulin shots with a once-a-month or twice-a-month treatments for type 2 diabetes.

Scientists, including one of Indian origin, have developed a technology that may provide weeks of glucose control for diabetes with a single injection, which would be a dramatic improvement over current therapies. In primates, the treatment has been shown to last for weeks, rather than days, researchers at Duke University in the US said.

Many current treatments for type 2 diabetes use a signalling molecule called glucagon-like peptide-1 (GLP1) to cause the pancreas to release insulin to control blood sugar. However, this peptide has a short half-life and is cleared from the body quickly. Researchers, including Ashutosh Chilkoti, from Duke University, have created a technology that fuses GLP1 to a heat-sensitive elastin-like polypeptide (ELP) in a solution that can be injected into the skin through a standard needle. Once injected, the solution reacts with body heat to form a biodegradable gel-like “depot” that slowly releases the drug as it dissolves.

In animal experiments, the resulting therapy provided glucose control up to three times longer than treatments currently on the market. Researchers systematically worked to vary the design of the delivery biopolymer at the molecular level and found a sweet spot that maximised the duration of the drug’s delivery from a single injection. “By doing so, we managed to triple the duration of this short-acting drug for type 2 diabetes, outperforming other competing designs,” said Chilkoti, senior author of study published in the journal Nature Biomedical Engineering. Researchers optimised their solution to regulate glucose levels in mice for 10 days after a single injection, up from the previous standard of 2-3 days.

In further tests, the team found that the optimised formulation improved glucose control in rhesus monkeys for more than 14 days after a single injection, while also releasing the drug at a constant rate for the duration of the trial. “What is exciting about this work was our ability to demonstrate that the drug could last over two weeks in non-human primates,” said Kelli Luginbuhl, a PhD student in the Chilkoti lab and co-author of the study.

source : The Indian Express : http://indianexpress.com/article/lifestyle/health/once-a-month-diabetes-treatment-may-replace-daily-insulin-jabs-4692143/

WELCOME TO DIABETES CARE UNIT

Hello Everyone,

As name suggest, this is the blog on diabetes. Our website, www.diabetescareunit.com, is also coming soon. Through which, We are going to provide information about diabetes and help you in controlling the blood sugar level. We also save your medical records which, in case of  emergency, you can get from anywhere by login on this website.